Novacyt S.A. (EPA:ALNOV)
France · Delayed Price · Currency is EUR 0.5200
-0.1200 (-18.75%)
May 14, 2026, 5:35 PM CET
Novacyt Market Cap
Novacyt has a market cap or net worth of €46.38 million as of May 14, 2026. Its market cap has increased by 45.85% in one year.
Market Cap
46.38M
Enterprise Value
36.39M
Revenue
22.96M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.52
Market Cap Chart
Since October 12, 2012, Novacyt's market cap has increased from 23.55M to 46.38M, an increase of 96.88%. That is a compound annual growth rate of 5.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2026 | 57.75M | 109.47% |
| Dec 31, 2025 | 27.57M | -35.08% |
| Dec 31, 2024 | 42.47M | -15.60% |
| Dec 29, 2023 | 50.32M | -42.02% |
| Dec 30, 2022 | 86.78M | -71.94% |
| Dec 31, 2021 | 309.30M | -55.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eurobio Scientific Société anonyme | 235.60M |
| Median Technologies | 183.43M |
| Carvolix | 178.92M |
| Guerbet | 126.03M |
| Diagnostic Medical Systems | 34.19M |
| Theraclion | 30.28M |
| Implanet | 28.76M |
| Biosynex | 24.37M |